Advertisement

Human Cell

, Volume 32, Issue 2, pp 141–149 | Cite as

Regulatory T cells regulate the distribution of natural killer T cells through CD39 signal transduction in asthma

  • Yanming LuEmail author
  • Yaqin Li
  • Wenjing Zhou
  • Bo Ding
  • Qing Yu
Research Article

Abstract

Natural killer T cells (NKT cells) and regulatory T cells (Treg cells) are two important immune regulatory cells which both play critical roles in asthma. Our previous experiments revealed that activation of Treg cells suppressed NKT cells in asthma. However, the possible regulatory effects and the mechanisms linking Treg cells and NKT cells remain poorly understood. The current study was designed to further investigate the regulatory effect and its possible mechanisms of Treg cells on NKT cells function, especially the distribution of NKT cells. Regulatory T cell (Treg), responder T cell (Teff) and Natural killer T cell (NKT) were isolated and purified. After Lentivirus carrying CD39 (Le-CD39) was transfected into Treg cells, the immune phenotype of Treg cells was changed and the suppressive effect of Treg cells on Teff cells with an activation of Treg cells was enhanced, marking with a high expression level of interleukin 10 (IL-10) and transforming growth factor β (TGF-β). Up-regulation of CD39 expression led to lower ATP level in cell culture supernatant. To further explore its function in asthma, we introduced an ovalbumin (OVA)-induced mice model of asthma. And the data showed that up-regulation of CD39 remarkably alleviated OVA-induced hallmarks of the asthma and increased NKT cells in the spleen and peripheral blood; however, decreased NKT cells in the lung. Furthermore, up-regulation of CD39 decreased the levels of interleukin 4 (IL-4) and interferon γ (IFN-γ) in the lung of OVA-treated mice. Our results strongly suggest that Treg cells could be activated by CD39 signal transduction and then affected the distribution of NKT cells in the OVA-induced mice model of asthma.

Keywords

Asthma Regulatory T cell NKT cell CD39 signal transduction 

Notes

Author contributions

YL carried out the study and the data statistics, YL participated in study design and drafted the manuscript, WZ supervised the study, BD and QY contributed to the scientific discussion of the data.

Funding

This study was financially supported by Scientific research project of Shanghai health and Family Planning Commission (no. 201640018).

Compliance with ethical standards

Conflict of interest

The authors have declared that no competing interests exist.

Consent for publication

This study is approved by all authors for publication.

Ethical approval

All animal experiments were approved by Renji Hospital, School of Medicine, Shanghai Jiao Tong University Institutional Animal Ethics Committee and were carried out according to the institutional guidelines from the Principles of Laboratory Animal Care of Renji Hospital, School of Medicine, Shanghai Jiao Tong University.

Availability of data and supporting materials

The datasets supporting the conclusions of this article are included within the article. Any additional information related to this study is available from the author for correspondence upon reasonable request.

References

  1. 1.
    Schatz M, Rosenwasser L. The allergic asthma phenotype. J Allergy Clin Immunol Pract. 2014;2:645–8.CrossRefGoogle Scholar
  2. 2.
    Chapman DG, Irvin CG. Mechanisms of airway hyper-responsiveness in asthma: the past, present and yet to come. Clin Exp Allergy. 2015;45:706–19.CrossRefPubMedCentralGoogle Scholar
  3. 3.
    Wang J, Jin RG, Xiao L, Wang QJ, Yan TH. Anti-asthma effects of synthetic salidroside through regulation of Th1/Th2 balance. Chin J Nat Med. 2014;12:500–4.Google Scholar
  4. 4.
    Hu B, Feng X, Wang L, Song Y, Ni X. 5-BDBD ameliorates an OVA-induced allergic asthma by the reduction of Th2 cytokines production. Iran J Basic Med Sci. 2018;21:364–9.PubMedCentralGoogle Scholar
  5. 5.
    Ding F, Fu Z, Liu B. Lipopolysaccharide Exposure Alleviates Asthma in Mice by Regulating Th1/Th2 and Treg/Th17 Balance. Med Sci Monit. 2018;24:3220–9.CrossRefPubMedCentralGoogle Scholar
  6. 6.
    Shi YH, Shi GC, Wan HY, et al. Coexistence of Th1/Th2 and Th17/Treg imbalances in patients with allergic asthma. Chin Med J (Engl). 2011;124:1951–6.Google Scholar
  7. 7.
    Park BS, Hong GU, Ro JY. Foxp3(+)-Treg cells enhanced by repeated low-dose gamma-irradiation attenuate ovalbumin-induced allergic asthma in mice. Radiat Res. 2013;179:570–83.CrossRefGoogle Scholar
  8. 8.
    Pumputiene I, Emuzyte R, Siaurys A, Tamosiunas V, Valiulis A. CD4+ CD25(high) Treg cells in peripheral blood during remission and exacerbation of allergic asthma in children. Acta Paediatr. 2011;100:1006–10.CrossRefGoogle Scholar
  9. 9.
    Joller N, Lozano E, Burkett PR, et al. Treg cells expressing the coinhibitory molecule TIGIT selectively inhibit proinflammatory Th1 and Th17 cell responses. Immunity. 2014;40:569–81.CrossRefPubMedCentralGoogle Scholar
  10. 10.
    Lu Y, Li Y, Xu L, Xia M, Cao L. Bacterial lysate increases the percentage of natural killer T cells in peripheral blood and alleviates asthma in children. Pharmacology. 2015;95:139–44.CrossRefGoogle Scholar
  11. 11.
    Nambiar J, Clarke AW, Shim D, et al. Potent neutralizing anti-CD1d antibody reduces lung cytokine release in primate asthma model. MAbs. 2015;7:638–50.CrossRefPubMedCentralGoogle Scholar
  12. 12.
    Nguyen KD, Vanichsarn C, Nadeau KC. Increased cytotoxicity of CD4+ invariant NKT cells against CD4+ CD25hiCD127lo/− regulatory T cells in allergic asthma. Eur J Immunol. 2008;38:2034–45.CrossRefPubMedCentralGoogle Scholar
  13. 13.
    Thorburn AN, Foster PS, Gibson PG, Hansbro PM. Components of Streptococcus pneumoniae suppress allergic airways disease and NKT cells by inducing regulatory T cells. J Immunol. 2012;188:4611–20.CrossRefGoogle Scholar
  14. 14.
    Lu Y, Guo Y, Xu L, Li Y, Cao L. Foxp3 regulates ratio of Treg and NKT cells in a mouse model of asthma. Mol Cell Biochem. 2015;403:25–31.CrossRefGoogle Scholar
  15. 15.
    Rissiek A, Baumann I, Cuapio A, et al. The expression of CD39 on regulatory T cells is genetically driven and further upregulated at sites of inflammation. J Autoimmun. 2015;58:12–20.CrossRefGoogle Scholar
  16. 16.
    Li P, Gao Y, Cao J, et al. CD39+ regulatory T cells attenuate allergic airway inflammation. Clin Exp Allergy. 2015;45:1126–37.CrossRefGoogle Scholar
  17. 17.
    Canale FP, Ramello MC, Montes CL. CD39 as a marker of pathogenic CD8+ T cells in cancer and other chronic inflammatory diseases. Oncoscience. 2018;5:65–6.PubMedCentralGoogle Scholar
  18. 18.
    Borsellino G, Kleinewietfeld M, Di Mitri D, et al. Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression. Blood. 2007;110:1225–32.CrossRefGoogle Scholar
  19. 19.
    Asano T, Meguri Y, Yoshioka T, et al. PD-1 modulates regulatory T-cell homeostasis during low-dose interleukin-2 therapy. Blood. 2017;129:2186–97.CrossRefPubMedCentralGoogle Scholar
  20. 20.
    Noval Rivas M, Chatila TA. Regulatory T cells in allergic diseases. J Allergy Clin Immunol. 2016;138:639–52.CrossRefGoogle Scholar
  21. 21.
    Tang Y, Jiang L, Zheng Y, Ni B, Wu Y. Expression of CD39 on FoxP3+ T regulatory cells correlates with progression of HBV infection. BMC Immunol. 2012;13:17.CrossRefPubMedCentralGoogle Scholar
  22. 22.
    Lu Y, Wang X, Gu J, et al. iTreg induced from CD39(+) naive T cells demonstrate enhanced proliferate and suppressive ability. Int Immunopharmacol. 2015;28:925–30.CrossRefGoogle Scholar
  23. 23.
    Idzko M, Ayata K, Müller C. T, et al: Attenuated allergic airway inflammation in Cd39 null mice. Allergy. 2013;68:472–80.CrossRefPubMedCentralGoogle Scholar
  24. 24.
    Li P, Yang QZ, Wang W, Zhang GQ, Yang J. Increased IL-4- and IL-17-producing CD8+ cells are related to decreased CD39+CD4+Foxp3+ cells in allergic asthma. J Asthma. 2018;55(1):8–14.CrossRefGoogle Scholar
  25. 25.
    Cicala C, Ialenti A. Adenosine signaling in airways: toward a promising antiasthmatic approach. Eur J Pharmacol. 2013;714:522–5.CrossRefGoogle Scholar

Copyright information

© Japan Human Cell Society and Springer Japan KK, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of Pediatrics, South Campus, Renji Hospital, School of MedicineShanghai Jiao Tong UniversityShanghaiPeople’s Republic of China

Personalised recommendations